These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11858397)

  • 41. Implication of Left Bundle Branch Block-Related Cardiac Memory in the Initiation of Torsades de Pointes.
    Yoshida K; Nakajima T; Kaneko Y; Kurabayashi M
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):757-8. PubMed ID: 26617175
    [No Abstract]   [Full Text] [Related]  

  • 42. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tiapride-induced torsade de pointes.
    Iglesias E; Esteban E; Zabala S; Gascon A
    Am J Med; 2000 Oct; 109(6):509. PubMed ID: 11184770
    [No Abstract]   [Full Text] [Related]  

  • 44. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hemiparesis and torsade de pointes under low-dose sotalol therapy].
    Sieber C; Weiss P; Follath F
    Schweiz Med Wochenschr; 1990 Sep; 120(38):1397-9. PubMed ID: 1699270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In-hospital monitoring of T-wave alternans in a case of amiodarone-induced torsade de pointes: clinical and methodologic insights.
    Kawaguchi T; Takasugi N; Kubota T; Takasugi M; Kanamori H; Ushikoshi H; Hattori A; Aoyama T; Kawasaki M; Nishigaki K; Takemura G; Minatoguchi S; Verrier RL
    Europace; 2012 Sep; 14(9):1372-4. PubMed ID: 22389418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation.
    Di Diego JM; Belardinelli L; Antzelevitch C
    Circulation; 2003 Aug; 108(8):1027-33. PubMed ID: 12912819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulpiride induced torsade de pointes.
    Huang BH; Hsia CP; Chen CY
    Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.
    Vieweg WV; Wood MA
    Psychosomatics; 2004; 45(5):371-7. PubMed ID: 15345781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.
    Sarganas G; Garbe E; Klimpel A; Hering RC; Bronder E; Haverkamp W
    Europace; 2014 Jan; 16(1):101-8. PubMed ID: 23833046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report.
    Tacken MC; Bracke FA; Van Zundert AA
    Acta Anaesthesiol Belg; 2011; 62(2):105-8. PubMed ID: 21919379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microvolt T-wave alternans monitoring in a patient with levofloxacin-induced Torsade de Pointes.
    Sahashi Y; Takasugi N; Naruse G; Kubota T; Nishigaki K; Minatoguchi S
    J Electrocardiol; 2018; 51(1):108-110. PubMed ID: 29126547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prolongation of the QT interval and torsade de pointes caused by ketanserin].
    Arfiero S; Ometto R; Vincenzi M
    G Ital Cardiol; 1990 Sep; 20(9):869-72. PubMed ID: 2079190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. QT prolongation and torsade de pointes associated with solifenacin in an 81-year-old woman.
    Asajima H; Sekiguchi Y; Matsushima S; Saito N; Saito T
    Br J Clin Pharmacol; 2008 Dec; 66(6):896-7. PubMed ID: 18823303
    [No Abstract]   [Full Text] [Related]  

  • 59. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.
    Silvetti MS; Drago F; Bevilacqua M; Ragonese P
    Ital Heart J; 2001 Mar; 2(3):231-6. PubMed ID: 11305536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics.
    Calderone V; Testai L; Martinotti E; Del Tacca M; Breschi MC
    J Pharm Pharmacol; 2005 Feb; 57(2):151-61. PubMed ID: 15720777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.